MedTrace Logo

The MIRROR Registry: Minimally Invasive IntRaceRebral HemORrhage Evacuation

NCT04494295 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2026-02-06

No results posted yet for this study

Summary

This registry will study the use of the Aurora® Surgiscope to provide surgical access and visualization in minimally invasive removal of hematoma in the brain. Many methods of hematoma removal are available and will be based on surgeon preference. The impact of patient selection and time to surgery from last known well time will be explored.

Conditions

  • Supratentorial Hemorrhage

Interventions

DEVICE

Aurora Surgiscope System

MIS evacuation of hematoma using the Aurora Surgiscope System

Sponsors & Collaborators

Principal Investigators

  • Sigmund Kulessa · Integra LifeSciences Corporation

  • Christopher Kellner, MD · Icahn School of Medicine at Mount Sinai

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-23
Primary Completion
2028-10-15
Completion
2029-10-15
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04494295 on ClinicalTrials.gov